Earnings History Data for IGM Biosciences, Inc. (IGMS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
IGM Biosciences, Inc.
IGM Biosciences Inc. is a biotechnology company. It engages in the research and development of engineered Immunoglobulin M antibodies for the treatment of cancer patients. The company's lead product candidate is IGM-2323, a bispecific T cell engaging IgM, which are in clinical stage. IGM Biosciences Inc. is based in Mountain View, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-11-2024 | PM | IGMS | IGM Biosciences | 865.00 | -1.01 | -0.82 | 0.00 | IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M [11/8/2024 7:30 AM] |
12.58 | -1.79 (-12.46%) |
15.08 | 0.71 (4.94%) |
4.12 - 22.50 | 487,996 | 160,000 | 7,257 | ||
| 14-08-2024 | PM | IGMS | IGM Biosciences | 521.00 | -0.79 | 0.03 | 0.00 | IGM Biosciences GAAP EPS of -$0.79, revenue of $1.26M [8/14/2024 7:49 AM] |
8.79 | -0.09 (-0.96%) |
0.0 | 0.0 (0.00%) |
3.81 - 17.70 | 138,612 | 230,000 | 0 | ||
| 08-05-2024 | AH | IGMS | IGM Biosciences | 590.00 | -0.83 | -0.84 | 0.00 | IGM Biosciences GAAP EPS of -$0.83 misses by $0.01, revenue of $0.5M misses by $0.28M [5/9/2024 12:44 PM] |
10.24 | 0.90 (9.64%) |
9.12 | -0.22 (-2.36%) |
3.81 - 17.70 | 190,614 | 310,000 | 2,613 | ||
| 07-03-2024 | AH | IGMS | IGM Biosciences | 706.00 | -1.01 | -1.06 | 0.00 | IGM Biosciences GAAP EPS of -$1.01 beats by $0.08, revenue of $0.7M misses by $0.07M [3/7/2024 5:21 PM] |
12.56 | 0.43 (3.54%) |
12.13 | 0.0 (0.00%) |
3.81 - 20.83 | 309,634 | 200,000 | 2,358 | ||
| 13-11-2023 | PM | IGMS | IGM Biosciences | 261.00 | -1.04 | -1.25 | 0.00 | IGM Biosciences GAAP EPS of -$1.04 beats by $0.21, revenue of $0.51M misses by $0.34M [11/14/2023 1:48 AM] |
4.78 | 0.13 (2.80%) |
4.50 | -0.15 (-3.23%) |
3.81 - 28.20 | 330,227 | 390,000 | 1,876 | ||
| 03-08-2023 | AH | IGMS | IGM Biosciences | 446.00 | -1.43 | -1.43 | 0.00 | IGM Biosciences GAAP EPS of -$1.43 beats by $0.01, revenue of $0.45M misses by $0.34M [8/3/2023 5:41 PM] |
9.07 | -0.43 (-4.53%) |
9.50 | 0.0 (0.00%) |
8.51 - 28.20 | 289,695 | 170,000 | 2,572 | ||
| 12-05-2023 | PM | IGMS | IGM Biosciences | 580.00 | -1.33 | -1.37 | 0.00 | IGM Biosciences GAAP EPS of -$1.33 beats by $0.01, revenue of $0.52M misses by $0.79M [5/12/2023 9:50 AM] |
12.97 | 0.05 (0.39%) |
0.0 | 0.0 (0.00%) |
9.74 - 28.20 | 295,064 | 210,000 | 0 | ||
| 30-03-2023 | AH | 9:05 AM ET (Mar 30) |
IGMS | IGM Biosciences, Inc. | 930.62 | -1.19 | -1.50 | -1.50 | 13.86 | -3.16 (-18.57%) |
16.95 | -0.07 (-0.41%) |
12.67 - 28.41 | 735,674 | 260,000 | 1,326 | ||
|
|
||||||||||||||||||
| 09-08-2021 | AH | 4:05 PM ET (Aug 9) |
IGMS | Igm Biosciences, Inc. | 2,529 | -1.16 | -1.21 | 0.00 | IGM Biosciences EPS beats by $0.04 [8/9/2021 4:47 PM] |
85.11 | 2.86 (3.48%) |
82.25 | 0.0 (0.00%) |
41.41 - 133.00 | 98,354 | 220,000 | 450 | |
| 06-05-2021 | AH | IGMS | IGM Biosciences, Inc. | 1,980 | -0.95 | -0.98 | -0.58 | IGM Biosciences EPS beats by $0.02 [5/6/2021 5:20 PM] |
66.97 | 8.21 (13.97%) |
58.76 | 0.0 (0.00%) |
41.41 - 133.00 | 229,494 | 160,000 | 213 | ||
| 30-03-2021 | AH | 4:10 PM ET (Mar 30) |
IGMS | IGM Biosciences, Inc. | 2,500 | -0.79 | -0.74 | -0.49 | IGM Biosciences EPS beats by $0.08 [3/30/2021 4:21 PM] |
75.73 | 0.67 (0.89%) |
75.06 | 0.0 (0.00%) |
41.41 - 133.00 | 521,366 | 240,000 | 1,766 | |
| 05-11-2020 | PM | IGMS | IGM Biosciences, Inc. | 1,630 | -0.66 | -0.69 | -2.41 | IGM Biosciences EPS beats by $0.03 [11/5/2020 7:34 AM] |
48.92 | -0.58 (-1.17%) |
49.20 | -0.30 (-0.61%) |
19.43 - 89.81 | 255,583 | 278,626 | 195 | ||
|
|
||||||||||||||||||
| 06-08-2020 | AH | IGMS | IGM Biosciences, Inc. | 1,610 | -0.62 | -0.65 | 0.00 | IGM Biosciences EPS beats by $0.03 [8/6/2020 5:04 PM] |
52.95 | 1.17 (2.26%) |
54.52 | 0.0 (0.00%) |
16.10 - 80.55 | 18,206 | 118,456 | 1,193 | ||
|
|
||||||||||||||||||